LINC00668 Modulates SOCS5 Expression Through Competitively Sponging miR-518c-3p to Facilitate Glioma Cell Proliferation.


Journal

Neurochemical research
ISSN: 1573-6903
Titre abrégé: Neurochem Res
Pays: United States
ID NLM: 7613461

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 15 09 2019
accepted: 13 02 2020
revised: 02 01 2020
pubmed: 13 4 2020
medline: 30 3 2021
entrez: 13 4 2020
Statut: ppublish

Résumé

Glioma is a common invasive cancer with unfavorable prognosis in patients. Long non-coding RNAs (lncRNAs) exert significant functions in carcinogenesis of various cancers including glioma. Among them, long intergenic non-coding RNA 668 (LINC00668) was reported to function as oncogene in various cancers, but its molecular mechanism in glioma has not been thoroughly researched. Our current study aimed to investigate the role and molecular mechanism of LINC00668 in glioma cells. We initially found out that LINC00668 was up-regulated in glioma cells. Through a series of function assays, LINC00668 was verified to facilitate cell proliferation and inhibit apoptosis in glioma. Then, by means of online databases, RNA pull down assay and RIP assay, we verified the binding relation between LINC00668 and miR-518c-3p. Also, the next function assays exposed that miR-518c-3p was the tumor suppressor in glioma cells. Similarly, SOCS5 (suppressor of cytokine signaling 5) was found to bind with miR-518c-3p, which repressed glioma tumorigenesis by targeting SOCS5. Moreover, rescue assays manifested that LINC00668 modulated expression of SOCS5 in a miR-518c-3p-dependent way and further regulated glioma tumorigenesis. Overall, LINC00668 modulates SOCS5 expression through competitively sponging miR-518c-3p to facilitate glioma cell proliferation.

Identifiants

pubmed: 32279214
doi: 10.1007/s11064-020-02988-2
pii: 10.1007/s11064-020-02988-2
doi:

Substances chimiques

MIRN518 microRNA, human 0
MicroRNAs 0
RNA, Long Noncoding 0
SOCS5 protein, human 0
Suppressor of Cytokine Signaling Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1614-1625

Subventions

Organisme : Shanxi Applied Basic Research Project
ID : No. 201801D121293

Auteurs

Zhenyang Liu (Z)

Department of Neurosurgery, Shanxi Dayi Hospital, 99 Longcheng Street, 030000, Taiyuan, People's Republic of China.

Junyu Wang (J)

Department of Neurosurgery, Changzheng Hospital, Naval Medical University, 415 Fengyang Rd, 20003, Shanghai, China.

Haibo Tong (H)

Department of Neurosurgery, Shanxi Dayi Hospital, 99 Longcheng Street, 030000, Taiyuan, People's Republic of China. 13653416075@163.com.

Xiangyang Wang (X)

Department of Neurosurgery, Shanxi Dayi Hospital, 99 Longcheng Street, 030000, Taiyuan, People's Republic of China.

Dong Zhang (D)

Department of Neurosurgery, Shanxi Dayi Hospital, 99 Longcheng Street, 030000, Taiyuan, People's Republic of China.

Qin Fan (Q)

Department of Neurosurgery, Shanxi Dayi Hospital, 99 Longcheng Street, 030000, Taiyuan, People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH